GH Research PLC (GHRS)
$20.45-2.90%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $1.4B
- Beta
- 1.33
- P/E (TTM)
- -21.52
- Short % float
- 5.31%
- Days to cover
- 14.3
- SI change
- -12.3%
- 1W
- -10.54%
- 1M
- -25.80%
- vs SPY 1W
- -12.10%
- vs SPY 1M
- -27.56%
Industry peers
FMP comparable companies · ranked by market cap
- PVLASELLPalvella Therapeutics, Inc.$1.9BCRISISQ 13$132.16+0.57%
- NBTXSELLNanobiotix S.A.$1.3BCRISISQ 17$25.10-6.99%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 5$20.93-2.06%
- SVRASELLSavara Inc.$980MCRISISQ 11$4.78-1.02%
- KURASELLKura Oncology, Inc.$943MBEARQ 12$10.62-1.41%
- ABUSSELLArbutus Biopharma Corp$923MCRISISQ 13$4.67-2.56%
- PROKSELLProKidney Corp.$531MCRISISQ 1$1.58+5.73%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-12.5%
REV YoY-
ROE-20.9%
EPS YoY-
ROA-16.7%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-21.52
P/E FWD-
SECTOR PE20.12
INDUSTRY PE13.79
P/B3.98
P/FCF-
EV/EBITDA-18.32
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.10
ALTMAN Z-
CURR RATIO28.70
ND/EBITDA-
BETA1.33
